SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-032189
Filing Date
2022-11-14
Accepted
2022-11-14 16:53:47
Documents
86
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1598024
2 ex10-1.htm EX-10.1 104940
3 ex31-1.htm EX-31.1 16014
4 ex31-2.htm EX-31.2 16253
5 ex32-1.htm EX-32.1 9164
  Complete submission text file 0001493152-22-032189.txt   8377454

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qlgn-20220930.xsd EX-101.SCH 66177
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qlgn-20220930_cal.xml EX-101.CAL 75524
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qlgn-20220930_def.xml EX-101.DEF 289807
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qlgn-20220930_lab.xml EX-101.LAB 511473
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qlgn-20220930_pre.xml EX-101.PRE 419560
80 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1467946
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 221387045
SIC: 2834 Pharmaceutical Preparations